APA (7th ed.) Citation

Hadjiaggelidou, C., Yiannaki, E., Markala, D., Triantafyllou, T., Gkastari, V., Verrou, E., . . . Papanikolaou, A. (2019). Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: Correlations with treatment outcome. Annals of Hematology, 98(6), 1457. https://doi.org/10.1007/s00277-019-03657-3

Chicago Style (17th ed.) Citation

Hadjiaggelidou, Christina, et al. "Evaluation of Regulatory T Cells (Tregs) Alterations in Patients with Multiple Myeloma Treated with Bortezomib or Lenalidomide Plus Dexamethasone: Correlations with Treatment Outcome." Annals of Hematology 98, no. 6 (2019): 1457. https://doi.org/10.1007/s00277-019-03657-3.

MLA (9th ed.) Citation

Hadjiaggelidou, Christina, et al. "Evaluation of Regulatory T Cells (Tregs) Alterations in Patients with Multiple Myeloma Treated with Bortezomib or Lenalidomide Plus Dexamethasone: Correlations with Treatment Outcome." Annals of Hematology, vol. 98, no. 6, 2019, p. 1457, https://doi.org/10.1007/s00277-019-03657-3.